Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mikrobiomik logo — rethinking microbiome

Mikrobiomik

rethinking microbiome

Founded 2018 Spain Spain 23 employees Series Unknown Total: $2.10M Biopharma, Biotechnology +1

General Information

Company Name Mikrobiomik
Founded Year 2018
Location Spain Spain +1
Employees 23
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when Mikrobiomik moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mikrobiomik

Mikrobiomik is a bio-pharmaceutical company with the slogan "rethinking microbiome." Founded in 2018 in Spain, the company is focused on researching and developing medicines based on the human microbiome. Mikrobiomik's vision is to be the first company worldwide to bring a medicine based on faecal microbiota to the EU market. They are currently in discussions with the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) to establish protocols for securing an MAA (Marketing Authorization Application) through a centralised procedure. In their pursuit, Mikrobiomik aims to lead the paradigm shift in designing therapeutic solutions based on the human microbiome. Their values revolve around pursuing excellence in processes, empathizing with chronic patients without curative treatments, and networking with all stakeholders in the biopharma, biotechnology, health, and wellness sectors. The latest investment rounds saw Mikrobiomik securing a €1.10M Venture Round investment on 10 September 2023, with participation from Seed Capital Bizkaia and Orza Investments.

Taxonomy: bio-pharmaceutical, human microbiome, medicine development, regulatory requirements, marketing authorization, EMA, AEMPS, therapeutic solutions, chronic patients, paradigm shift

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 2
Investor
•••• •••• 		10 Sep 2023
Venture Round •••••• 1
Investor
03 Dec 2021
Grant •••••• - 04 Jan 2021
Pre Seed Round •••••• 1 •••• •••• 16 Apr 2019

Mikrobiomik Alternatives & Competitors

Mikrobiomik vs
SNIPR Biome - A CRISPR Company
SNIPR Biome - A CRISPR Company Denmark

Clinical CRISPR and Gene Therapy of the Microbiome Company

Series B
41 employees
Biotechnology, Health Care
Mikrobiomik vs
LUCA Biologics
LUCA Biologics United States

Living medicines targeting the vaginal microbiome to impact women's health. A Seed Health foundry c...

Seed
4 employees
Biotechnology, Health Care
Mikrobiomik vs
CC Bio
CC Bio United Kingdom

Harnessing synthetic biology for the development of novel microbiome editing therapeutics

4 employees
Biopharma, Biotechnology

FAQ About Mikrobiomik

rethinking microbiome
Mikrobiomik was founded in 2018.
Mikrobiomik is headquartered in Spain.
Mikrobiomik operates in the following industries: Biopharma, Biotechnology, Health and Wellness.
Mikrobiomik has approximately 23 employees.
Mikrobiomik has completed 4 funding rounds, raising a total of $2.10M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Mikrobiomik include SNIPR Biome - A CRISPR Company, LUCA Biologics, CC Bio, SFA Therapeutics, Anatara Lifesciences Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mikrobiomik and SNIPR Biome - A CRISPR Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mikrobiomik and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy